Structure-directed mutagenesis produces thermostable SARS-CoV-2 spike protein trimers with potential vaccine booster applications

Specialist researcher holding microscope slide analyzing blood sample working at coronavirus vaccine development during virus examination in microbiology hospital laboratory. Biochemistry experiment

Researchers investigated the change in the stability, antigenicity, and protein expression of the SARS-CoV-2 spike protein trimer using structure-directed mutagenesis to alter a cavity in the core of the spike protein.

Oral deucravacitinib shows promise in patients with active lupus

Previous article

Dirt-cheap solar evaporation could solve the world’s soil pollution problem

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in News